MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Synergy Life Science Partners
iRhythm Technologies, Inc. (NASDAQ:IRTC)*
Organization & Developments: iRhythm
Parents
iRhythm Technologies, Inc. (NASDAQ:IRTC)*
Children
*IRhythm makes the Zio Patch, a single-use, water-resistant, continuous cardiac rhythm monitoring device that can be worn for up to 14 days.
*It has the capacity to store up to 14 days of ECG, measuring every heartbeat and storing every heartbeat, and it samples 200 times a second
*It is meant to be an early diagnostic tool for patients who do not have symptoms of cardiac arrhythmia, or suffer from transient symptoms such as palpitations, dizziness, light-headedness, among others.
*The Zio Patch removes all the encumbrances of a traditional cardiac monitoring device and is simple and easy to use by patients.
2012: iRhythm Medical Magnetic Tape Recorder - FDA Clearnace (2012)
2014: ZIO Wireless Patch May Be Better Option Than Holter Monitors for Cardiac Arrhythmia Diagnosis (2014)
2019: iRhythm links with Verily to help diagnose 'silent' afib cases
2019: iRhythm-Verily Partnership: Interview with iRhythm CEO Kevin King_www.medgadget.com
2019: Stanford, iRhythm's deep neural network matches cardiologists at arrhythmia classification
2020: iRhythm stock leaps 33% after CMS pitches new reimbursement codes
2020: iRhythm wearable linked to more afib diagnoses in Aetna-backed study
2021: iRhythm's future hazy after Medicare pricing saga erases 12-month high
2022: iRhythm Technologies stock jumps on Q2 earnings beat |MD
2022: iRhythm: Fairly Priced At Current Multiples, No Need To Size Up_seekingalpha.com
2022: iRhythm: Revenue Upside Less Visible After Q3 Challenges_ seekingalpha.com
2022: Why Highly Rated iRhythm Technologies Is Making A 20% Jump Today
2023: iRhythm: Implied Expectations Appear Warranted, High Risk Priced In At Current Multiples
2024: Forecasting The Future: 6 Analyst Projections For iRhythm Technologies
2024: iRhythm Technologies, Inc. 2023 Q4 - Results - Earnings Call Presentation
2024: iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve
2025: iRhythm: Promising Outlook - So Long As Past Mistakes Are Not Repeated
Jumps
*Key People: iRhythm
Finance & Acquisitions: iRhythm